Biomarkers in dementia: clinical utility and new directions

Imaging, cerebrospinal fluid (CSF) and blood-based biomarkers have the potential to improve the accuracy by which specific causes of dementia can be diagnosed in vivo, provide insights into the underlying pathophysiology, and may be used as inclusion criteria and outcome measures for clinical trials...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, R M, Paterson, R W, Warren, J D, Zetterberg, H, O'Brien, J T, Fox, N C, Halliday, G M, Schott, J M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2014
Materias:
Cognitive Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335455/
https://www.ncbi.nlm.nih.gov/pubmed/25261571
http://dx.doi.org/10.1136/jnnp-2014-307662

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335455/
https://www.ncbi.nlm.nih.gov/pubmed/25261571
http://dx.doi.org/10.1136/jnnp-2014-307662

Ejemplares similares